Literature DB >> 19054673

5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.

Frank Ruebsam1, Chinh V Tran, Lian-Sheng Li, Sun Hee Kim, Alan X Xiang, Yuefen Zhou, Julie K Blazel, Zhongxiang Sun, Peter S Dragovich, Jingjing Zhao, Helen M McGuire, Douglas E Murphy, Martin T Tran, Nebojsa Stankovic, David A Ellis, Alberto Gobbi, Richard E Showalter, Stephen E Webber, Amit M Shah, Mei Tsan, Rupal A Patel, Laurie A Lebrun, Huiying J Hou, Ruhi Kamran, Maria V Sergeeva, Darian M Bartkowski, Thomas G Nolan, Daniel A Norris, Leo Kirkovsky.   

Abstract

5,6-Dihydro-1H-pyridin-2-one analogs were discovered as a novel class of inhibitors of genotype 1 HCV NS5B polymerase. Among these, compound 4ad displayed potent inhibitory activities in biochemical and replicon assays (IC(50) (1b)<10nM; IC(50) (1a)<25nM, EC(50) (1b)=16nM), good in vitro DMPK properties, as well as moderate oral bioavailability in monkeys (F=24%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054673     DOI: 10.1016/j.bmcl.2008.11.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents.

Authors:  Feng Ni; Smitha Kota; Virginia Takahashi; A Donny Strosberg; John K Snyder
Journal:  Bioorg Med Chem Lett       Date:  2011-04-15       Impact factor: 2.823

2.  Core as a novel viral target for hepatitis C drugs.

Authors:  Arthur Donny Strosberg; Smitha Kota; Virginia Takahashi; John K Snyder; Guillaume Mousseau
Journal:  Viruses       Date:  2010-08-20       Impact factor: 5.818

3.  Direct binding of a hepatitis C virus inhibitor to the viral capsid protein.

Authors:  Smitha Kota; Virginia Takahashi; Feng Ni; John K Snyder; A Donny Strosberg
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

4.  Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors.

Authors:  Sarah E Boyce; Neeraj Tirunagari; Anita Niedziela-Majka; Jason Perry; Melanie Wong; Elaine Kan; Leanna Lagpacan; Ona Barauskas; Magdeleine Hung; Martijn Fenaux; Todd Appleby; William J Watkins; Uli Schmitz; Roman Sakowicz
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

5.  Classification of HCV NS5B polymerase inhibitors using support vector machine.

Authors:  Maolin Wang; Kai Wang; Aixia Yan; Changyuan Yu
Journal:  Int J Mol Sci       Date:  2012-03-27       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.